Editorial
With this issue, we inaugurate the Dr. Abram Hoffer Lecture Series Award and publish the winning paper for 2018.
As readers of the JOM know, Abram Hoffer, MD, PhD, (1917 – 2009), was an innovative, pioneering scientist and psychiatrist who developed the first evidence-based nutritional treatment to support recovery for patients with psychotic episodes and schizophrenia.
The biennial award, administered by the Canadian College of Naturopathic Medicine, with the generous support of Orthomolecular Medicine, serves as a tribute to Dr. Hoffer’s decades-long career and his contributions as a psychiatrist and clinician researcher.
Eligible papers were required to focus on an aspect of orthomolecular treatment in the provision of patient care according to the CCNM/Journal of Orthomolecular Medicine submission guidelines. The Review Panel was comprised of: John Hoffer, MD, PhD (Professor, Faculty of Medicine, McGill University); Steven Carter (Director, International Society for Orthomolecular Medicine); Jonathan Prousky, ND (Professor and Chief Naturopathic Medical Officer, Canadian College of Naturopathic Medicine); and Bob Bernhardt, PhD (President and CEO, Canadian College of Naturopathic Medicine).
The paper, “Vitamin B12, Vitamin B6, Folic Acid and Psychosis: A Review” by Monique Aucoin, ND, and Laura LaChance, MD, was unanimously considered to be the best of the submissions, judged on its relevance to orthomolecular medicine, the quality of presented evidence, originality, and clarity. The winning paper received a $1,500 prize, and was featured at the Abram Hoffer Lecture Series event, held at CCNM on November 1, 2018
.
L to R: Sasha Tahiliani, Jonathan Prousky, Monique Aucoin, Bob Bernhardt, Steven Carter
